Smith & Nephew PLC
SNN32.845USD
+0.145+0.44%
Handelsschluss 12/19, 16:00（ET）Kurse um 15 Minuten verzögert
14.39BMarktkapitalisierung
29.22KGV TTM
mehr Informationen über Smith & Nephew PLC Unternehmen
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLC Informationen
BörsenkürzelSNN
Name des UnternehmensSmith & Nephew PLC
IPO-datumSep 18, 2087
CEONath (Deepak S)
Anzahl der mitarbeiter17349
WertpapierartDepository Receipt
GeschäftsjahresendeSep 18
AddresseBuilding 5
StadtWATFORD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlWD18 8YE
Telefon4401923477100
Websitehttps://www.smith-nephew.com/
BörsenkürzelSNN
IPO-datumSep 18, 2087
CEONath (Deepak S)
Führungskräfte von Smith & Nephew PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.08%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+28.58%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+0.95%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+2.62%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Andere
1.90B
32.62%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Andere
1.90B
32.62%
Aktionärsstatistik
Aktualisiert: Tue, Nov 18
Aktualisiert: Tue, Nov 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
Andere
97.55%
Aktionäre
Aktionäre
Anteil
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
Andere
97.55%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
3.66%
Research Firm
2.01%
Investment Advisor/Hedge Fund
1.51%
Hedge Fund
0.27%
Family Office
0.17%
Family Office
0.17%
Pension Fund
0.15%
Family Office
0.12%
Individual Investor
0.01%
Andere
91.94%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BMO Capital Markets (US)
3.20M
0.75%
+2.62M
+455.42%
Jun 30, 2025
River Road Asset Management, LLC
3.18M
0.75%
+270.48K
+9.30%
Jun 30, 2025
Scharf Investments, LLC
2.08M
0.49%
+6.99K
+0.34%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.60M
0.38%
+63.78K
+4.14%
Jun 30, 2025
Optiver Holding B.V.
1.15M
0.27%
+1.01M
+714.32%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
1.08M
0.25%
-18.79K
-1.72%
Jun 30, 2025
Parametric Portfolio Associates LLC
971.46K
0.23%
-1.36K
-0.14%
Jun 30, 2025
BNP Paribas Securities Corp. North America
644.52K
0.15%
+505.93K
+365.06%
Jun 30, 2025
Morgan Stanley & Co. LLC
823.55K
0.19%
+676.68K
+460.75%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Brandes International ETF
1.07%
ALPS Disruptive Technologies ETF
0.93%
ActivePassive International Equity ETF
0.2%
Avantis Responsible International Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.11%
Avantis International Equity ETF
0.07%
DFA Dimensional International Core Equity 2 ETF
0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
Anteil1.07%
ALPS Disruptive Technologies ETF
Anteil0.93%
ActivePassive International Equity ETF
Anteil0.2%
Avantis Responsible International Equity ETF
Anteil0.12%
SP Funds S&P World (ex-US) ETF
Anteil0.11%
Avantis International Equity ETF
Anteil0.07%
DFA Dimensional International Core Equity 2 ETF
Anteil0.04%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
Anteil0.01%
SGI Enhanced Global Income ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.64B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Aug 05, 2025
SNN.NB Final Cash Dividend of gross USD 0.3 paid on Nov 07, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Nov 07, 2025
Oct 03, 2025
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Smith & Nephew PLC?
Die fünf größten Anteilseigner von Smith & Nephew PLC sind:
BMO Capital Markets (US) hält 3.20M Aktien, was 0.75% der Gesamtaktien entspricht.
River Road Asset Management, LLC hält 3.18M Aktien, was 0.75% der Gesamtaktien entspricht.
Scharf Investments, LLC hält 2.08M Aktien, was 0.49% der Gesamtaktien entspricht.
Brandes Investment Partners, L.P. hält 1.60M Aktien, was 0.38% der Gesamtaktien entspricht.
Optiver Holding B.V. hält 1.15M Aktien, was 0.27% der Gesamtaktien entspricht.
BMO Capital Markets (US) hält 3.20M Aktien, was 0.75% der Gesamtaktien entspricht.
River Road Asset Management, LLC hält 3.18M Aktien, was 0.75% der Gesamtaktien entspricht.
Scharf Investments, LLC hält 2.08M Aktien, was 0.49% der Gesamtaktien entspricht.
Brandes Investment Partners, L.P. hält 1.60M Aktien, was 0.38% der Gesamtaktien entspricht.
Optiver Holding B.V. hält 1.15M Aktien, was 0.27% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Smith & Nephew PLC?
Die drei wichtigsten Anteilseigner-Typen von Smith & Nephew PLC sind:
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
Wie viele Institutionen halten Anteile an Smith & Nephew PLC (SNN)?
Mit Stand vom 2025Q3 halten 458 Institutionen Anteile an Smith & Nephew PLC, mit einem Gesamtmarktwert von etwa 32.77M, was 7.72% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -0.24% gestiegen.
Was ist die größte Einnahmequelle von Smith & Nephew PLC?
Am FY2024 erzielte das Geschäft mit Sports Medicine Joint Repair für Smith & Nephew PLC den höchsten Umsatz in Höhe von 982.00M, was 16.90% des Gesamtumsatzes entspricht.
